Immunologic parameters of multiple chemical sensitivity

Occupational Medicine - State of the Art Reviews

Volumn 15, Issue 3, 2000, Pages 647-665

  Mitchell, Clifford S ^a   Donnay, Albert ^b   Hoover, Donald R ^b   Margolick, Joseph B ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; MULTIPLE CHEMICAL SENSITIVITY; OCCUPATIONAL DISEASE; PREDICTION AND FORECASTING; QUALITY CONTROL; REPRODUCIBILITY; REVIEW;

HUMANS; IMMUNOLOGIC TESTS; MULTIPLE CHEMICAL SENSITIVITY; OCCUPATIONAL DISEASES; PREDICTIVE VALUE OF TESTS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 0344436798     PISSN: 0885114X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Cullen MR: The worker with multiple chemical sensitivities: An overview. Occup Med 2:655-661, 1987.
2. Levin AS, Byers VS: Environmental illness: A disorder of immune regulation. Occup Med 2:669-681, 1987.
3. Sparks PJ, Daniell W, Black D, et al: Multiple chemical sensitivity syndrome: A clinical perspective. J Occup Env Med 36:718-730, 1994.
4. Miller CS: Toxicant-induced loss of tolerance - an emergent theory of disease? Environ Health Perspec 105S2:445-453, 1997.
5. Unanue ER: Overview of the immune system. In Frank MM, Austen KF, Claman HN, et al (eds): Samter's Immunologic Diseases. 5th ed., Vol 1. Boston, Little, Brown and Company, 1995, pp 3-16.
6. Fauci AS: Immunopathogenic mechanisms in HIV-1 infection. Ann Intern Med 114:678-693, 1991.
7. Callan MFC, Steven N, Krausa P, et al: Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nature Medicine 2:906-911, 1996.
8. Carney WP, Rubin RH, Hoffman RA, et al: Analysis of T lymphocytes subsets in cytomegalovirus mononucleosis. J Immunol 126:2114-2116, 1981.
9. Landay A, Jessop C, Lennette ET, et al: Chronic fatigue syndrome: Clinical condition associated with immune activation. Lancet 338:707-712, 1991.
10. Morimoto CM, et al.: Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N Engl J Med 316:67, 1987.
11. Horwitz DA, Stohl W: T lymphocytes, cytokines, and immune regulation in systemic lupus erythematosus. In Wallace DJ, Hahn BH (eds): Dubois' Lupus Erythematosus, 4th ed. Philadelphia, Lea & Febiger, 1993, pp 83-96.
12. Parks DR, Herzenberg LA: Flow cytometry and fluorescence-activated cell sorting: theory, experimental optimization, and applications in lymphoid cell biology. Methods Enzymology 108:197-241, 1989.
13. Simon GE, Daniell W, Stockbridge H, et al: Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity: a controlled study. Ann Intern Med 119:97-103, 1993.
14. Margolick JB, Vogt RF: Controversy over multiple chemical sensitivities (letter). Ann Intern Med 220:249-249, 1994.
15. Koepke JA, Landay AL: Precision and accuracy of absolute lymphocyte counts. Clin Immunol Immunopathol 52:19-27, 1989.
16. Kagan J, Gelman R, Waxdal M, et al: Quality Assessment Program. Annals of NY Acad of Sci 677:50, 1993.
17. Paxton H, Kidd P, Landay A, et al: Results of the flow cytometry ACTG quality control program: Analysis and findings. Clin Immunol Immunopathol 52:68-84, 1989.
18. Landay AL, Brambilla D, Pitts J, et al: Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. Clin Diagnostic Lab Immunol 2:462-468, 1995.
19. Broughton A, Thrasher JD, Gard Z: Immunological evaluation of our arc welders exposed to fumes from ignited polyurethane (isocyanate) foam: Antibodies and immune profiles. Am J Indust Med 13:463-472, 1988.
20. Bernstein DI: Multiple chemical sensitivity: State of the art symposium: The role of chemical allergens. Reg Toxicol Pharmacol 24:S28-S31, 1996.
21. Albright JF, Goldstein RA: Is there evidence of an immunologic basis for multiple chemical sensitivity? Toxicol Indust Health 8:215-219, 1992.
22. Salvaggio JE: Understanding clinical immunological testing in alleged chemically induced environmental illnesses. Regul Toxicol Pharmacol 24:S16-S27, 1996.
23. Terr AI: Multiple chemical sensitivities: immunologic critique of clinical ecology theories and practice. Occup Med 2:683-695, 1987.
24. Meggs WJ: Immunological mechanisms of disease and the multiple chemical sensitivity syndrome. In Multiple Chemical Sensitivities: Addendum to biologic markers in immunotoxicology. National Research Council, Washington, DC, National Academy Press, 1992, pp 155-168.
25. Dietert RR, Hedge A: Chemical sensitivity and the immune system: A paradigm to approach potential immune involvement. NeuroToxicol 19:253-257, 1998.
26. Kreutzer R, Neutra RR, Lashuay N: Use of laboratory tests for immune biomarkers in environmental health studies concerned with exposure to indoor air pollutants. Environ Health Perspec 95:85-9112, 1991.
27. Graveling RA, Pilkington A, George PK, et al: A review of multiple chemical sensitivity. Occupat Environ Med 56:73-85, 1999.
28. Rea WJ, Bell IR, Suits CW, et al: Food and chemical susceptibility after environmental chemical overexposure: Case histories. Ann.Allergy 41:101-110, 1978.
29. Heuser G, Wojdani A, Heuser S: Diagnostic markers of multiple chemical sensitivity. In Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC, National Academy Press, 1992, pp 117-138.
30. Terr AI: Environmental illness: A clinical review of 50 cases. Arch Intern Med 146:145-149, 1986.
31. McGovern JJ Jr, Lazaroni JA, Hicks MF, et al: Food and chemical sensitivity: Clinical and immunologic correlates. Arch Otolaryngol Head Neck Surg 109:292-297, 1983.
32. Kipen H, Fiedler N, Maccia C, et al: Immunologic evaluation of chemically sensitive patients. Toxicol Ind Health 8:125-135, 1992.
33. Ziem G, McTamney J: Profile of patients with chemical injury and sensitivity. Environ Health Perspect 105:417-436, 1997.
34. Liu Z, Hultin LE, Cumberland WG, et al: Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: Results of 6 years of follow-up. Cytometry 26:1-7, 1996.
35. Liu Z, Cumberland WG, Hultin LE, et al: CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Aquir Immune Def Syndr 18:332-340, 1998.
36. Ascher MS, Sheppard HW: AIDS as immune system activation: A model for pathogenesis. Clin Exp Immunol 73:165-170, 1988.
37. Ascher MS, Sheppard HW: AIDS as immune system activation. II. The panergic imnesia hypothesis. J Acquir Immune Defic Syndr 3:177-191, 1990.
38. Fahey JL, Taylor JMG, Detels R, et al: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322:166-172, 1990.
39. AAAAI Board of Directors: Position statement: Idiopathic environmental intolerance. Allerg Clin Immunol 103:36-40, 1999.
40. American College of Physicians: Position paper: Clinical ecology. Ann Intern Med 111:168-178, 1989.
41. Council on Scientific Affairs AMA: Clinical ecology. JAMA 268:1634-1635, 1992.
42. McLellan RK, Becker CE, Borak JB, et al: Multiple chemical sensitivities: Idiopathic environmental intolerance. J Occup Environ Med 41:940-942, 1999.